Publication: Estudio piloto del cemento portland en el tratamiento de pulpotomía en molares temporales
Loading...
Official URL
Full text at PDC
Publication Date
2014
Authors
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Citations
Exportar
Abstract
Description
UCM subjects
Unesco subjects
Keywords
Citation
1. American Academy of Pediatric Dentistry (AAPD). Guedline on pulp therapy for primary and immature permanent teeth. 2009: 34(6); 12-13.
2. Barbería Leache E, Boj JR, Catalá M, Garcia-Ballesta C, Mendoza A. Odontopediatría. 2ªed. Barcelona: Masson; 2001.
3. Maroto Edo M, Barbería Leache E, Planells del Pozo P. Estudio clínico del agregado trióxido mineral en pulpotomías de molares temporales: estudio piloto a 15 meses. Revista del Consejo de Odontólogos y Estomatólogos. 2004: 9(1); 23-30.
4. Pachano B, Salas M, Torres A. Comportamiento clínico y radiográfico del formocresol y la pasta iodofórmada en el tratamiento de pulpotomíasen molares primarios. Acta odontológica Venezolana. 2009: 47(4); 1-13.
5. Bowen L, Mathu-Muju K, Nash D, Chance K, Bush H, Li HF. Pediatric and general dentists´attitudes toward pulp therapy for primary teeth. Pediatric Dentistry. 2012: 34(3); 210-5.
6. Rood HD, Whaterhouse PJ, Fuks AB, Fayle SA, Moffat MA. UK National Clinical Guidelines in Paediatric Dentistry. International Journal of Paediatric Dentistry. 2006: 16(1); 15-23.
7. Fernández Domínguez H, Mendoza Mendoza A, Solano Reina E. Pulpotomía: estudio comparativo entre glutaraldehído al 4% y formocresol al 20% en dientes temporales vitales. Odontología Pediátrica. 2000: 8(1); 19-25.
8. Waterhouse PJ, Nunn JH, Whitworth JM, Soames JV. Primary molar pulp therapy –histological evaluation of failure. International Journal of Paediatric Dentistry. 2000: 10; 313-21.
9. Morales de Armas M, Cabañas Lores C, Ramos Cardoso L. Uso de formocresol diluido en dientes temporales. Revista Cubana de Estomatología. 1998: 35(1); 5-10.
10. Dean JA, Mack RB, Fulkerson BT, Sanders BJ. Comparison of electrosurgical and formocresol pulpotomy procedures in children. International Journal of Paediatric Dentistry. 2002; 12: 177-82.
11. Liu J. Nd: YAG laser pulpotomy of human primary teeth. International Congress Series 1248. 2003: 251-6.
12. Saltzman B, Sigal M, Clokie C, Rukavina J, Titley K, Kulkarni GV. Assessment of a nobel alternative to conventional formocresol-zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode lasser-mineral trioxide aggregate pulpotomy. International Journal of Paediatric Dentistry.2005; 15: 437-47.
13. Maroto M, Barbería E, Vera V, Salazar Velásquez L. Contrastada experiencia clínica, a largo plazo, en el uso del agregado trióxido mineral en pulpotomías de dientes temporales. Gaceta Dental. 2007; 177: 76-89.
14. Waterhouse PJ, Nunn JH, Whitworth JM. An investigation of the relative efficacy of Buckley´s formocresol and calcium hydroxide in primary molar vital pulp therapy. British Dental Journal. 2000; 188(1): 32-6.
15. Fernández Delgado FJ, López Trujillo JM, Vallejo Bolaños E. Alternativas a la pulpotomía con formocresol en odontopediatría. Quintessence. 2001; 14: 385-92.
16. Ranly DM, García-Godoy F. Current and potential pulp therapies for primary and young permanent teeth. Journal of Dentistry. 2000; 28: 153-161.
17. Cuadros Fernández C. Estudio clínico comparativo de diferentes agentes pulpares en pulpotomías de molares primarios. (Tesis doctoral) Barcelona: Universitat Internacional de Catalunya. 2013.
18. Méndez Blanco VM, Alvarez Congost C, Alvarez Brasa C. Pulpotomías en la dentición decidua: buscando alternativas. Odontología Pediátrica. 1995; 4(3): 145-8.
19. Moretti ABS, Sakai VT, Oliveira TM, Fornetti APC, Santos CF, Machado MAAM, Abdo RCC. The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth. International Endodontic Journal. 2008; 41: 547–55.
20. Sönmez D, Durutürk L. Ca(OH)2 pulpotomy in primary teeth. Part I: internal resorption as a complication following pulpotomy. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2008; 106: e94-e98.
21. Cardoso ML, Aguirre MV, Quintero de Lucas GV, Nora Brandan C. Toxicidad in vitro del formocresol y sulfato férrico sobre macrófagos murinos. Odontología Pediátrica. 2008; 17(3): 153-62.
22. Smith NL, Seale NS, Nunn ME. Ferric sulfate pulpotomy in primary molars: A retrospective study. Pediatric Dentistry. 2000; 22:192-9.
23. de Coster P, Rajasekharan S, Martens L. Laser-assisted pulpotomy in primary teeth: a systematic review. International Journal of Paediatric Dentistry. 2013; 23:389-99.
24. Duarte B, Medina A, Pérez LL, Rodríguez MJ. Comparación clínica y radiográfica de pulpotomías realizadas con electrocauterio y formocresol en molares deciduos: estudio preliminar. Ustasalud Odontología. 2004; 3: 48-54.
25. Livaditis GJ. Comparison of monopolar and bipolar electrosurgical modes for restorative dentistry: A review of the literature. The Journal of Prosthetic Dentistry. 2001; 86: 390-9.
26. El-Meligy O, Abdalla M, El-Baraway S, El-Tekya M, A Dean J. Histological evaluation of electrosurgery and formocresol pulpotomy techniques in primary teeth in dogs. The Journal of Pediatric –dentistry. 2001; 26(1): 81-5.
27. Bahrololoomi Z, Moeintaghavi A, Emtiazi M, Hosseini G. Clinical and radiographic comparison of primary molars after formocresol and electrosurgical pulpotomy: A randomized clinical trial. Indian Journal of Dental Research. 2008; 19(3): 219-23.
28. Cardoso Silva C. Estudio clínico del Agregado Trióxido Mineral en pulpotomías de molares temporales. Comparación de resultados con MTA Gris y MTA Blanco [tesis doctoral] Madrid: Universidad Complutense de Madrid, Servicio de Publicaciones; 2010.
29. Waterhouse PJ, Nunn JH, Whitworth JM. Prostaglandin E2 and treatment outcome in pulp therapy of primary molars with carious exposures. International Journal of Paediatric Dentistry. 2002; 12: 116-23.
30. Vargas KG, Packham B, Lowman D. Preliminary evaluation of sodium hypochlorite for pulpotomies in primary molars. Pediatric Dentistry. 2006; 28(6): 511-7.
31. Maroto M, Barbería E, Vera V, García-Godoy F. Mineral trioxide aggregate as pulp dressing agent in pulpotomy treatment of primary molars: 42-month clinical study. American Journal of Dentistry. 2006; 20 (5): 283-6.
32. Srinivasan V, Waterhouse P, Whitworth J. Mineral trioxide aggregate in paediatric dentistry. International Journal of Paediatric Dentistry. 2009; 19: 34-47.
33. Camilleri J, Pitt Ford TR. Mineral trioxide aggregate: a review of the constituents and biological properties of the material. International Endodontic Journal. 2006; 39: 747-54.
34. Carlos Boveda. El odontólogo invitado. Aplicación clínica del Agregado Trióxido Mineral (MTA) en endodoncia. [Citado 2001] Disponible en: dirección: http://www.carlosboveda.com/Odontologosfolder/odontoinvitadoold/odontoinvitado7.html.
35. Maroto Edo M. Estudio clínico del agregado trióxido mineral en pulpotomías de molares temporales [tesis doctoral] Madrid: Universidad Complutense de Madrid, Servicio de Publicaciones; 2004.
36. Torabinejad M, White DJ. Tooth filling material and use. US Patent number 5,769, 638.
37. Cisneros Ruiz AC, García Aranda RL, Perea Mejía LM. Evaluación de la microfiltración bacteriana en obturaciones retrógradas con MTA, súper EBA, amalgama y cemento Portland en dientes extraídos. Revista Odontológica Mexicana. 2006; 10(4): 157-61.
38. Maroto M, Barbería E, Planells P, Vera V. Treatment of a non-vital immature incisor with mineral trioxide aggregate (MTA). Dental Traumatology. 2003; 19: 165-9.
39. Cardoso Silva C, Casimiro de Andrade D, Maroto Edo M, Barbería Leache E. Agregado de Trióxido Mineral (MTA). Aplicaçoes em Odontopediatria. Revista da Ordem dos Medicos Dentistas. 2010; 7: 14-22.
40. Maroto M, Barbería E, Planells P, García-Godoy F. Dentin bridge formation after mineral trioxide aggregate (MTA) pulpotomies in primary teeth. American Journal of dentistry. 2005; 18(3): 151-4.
41. Glickman GN, Kennth A. 21st-Century endodontics. The Journal of the American Dental Association. 2000; 131:39–46.
42. Dammaschke T, Gerth HUV, Züchner H, Schäfer E. Chemical and physical surface and bulk material characterization of white ProRoot MTA and two Portland cements. Dental Materials. 2005; 21:731-8.
43. Al-Hezaimi K, Al-Shalan T, Naghshbandi J, Simon J, Rotstein I. MTA preparations from different origins may vary in their antimicrobial activity. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2009; 107:e85-e88.
44. Asgary S, Parirokh M, Egbbal MJ, Brink F. Chemical differences between white and gray mineral trioxide aggregate. Journal of Endodontics. 2005; 31:101-3.
45. Hwang Y, Lee S, Hwang I, Kang I, Kim M, Kim S, Son H, Mann W. Chemical composition, radiopacity, and biocompatibility of Portland cement with bismuth oxide. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2009; 107:e96-e102.
46. Camilleri J, Montesin F, Brady K, Sweeney R, Curtis R, Pitt Ford T. The constitution of mineral trioxide aggregate. Dental Materials. 2005; 21 (4):297-303.
47. Takashi K, Larz S. Comparative analysis of the particle size and shape of commercially available mineral trioxide aggregates and Portland cement: a study with a flow particle image analyzer. Journal of Endodontics. 2008; 34(1):94-8.
48. Storm B, Eichmiller FC, Tordik PA, Goodell GG. Setting expansion of gray and white mineral trioxide aggregate and Portland cement. Journal of Endodontics. 2008; 34(1):80-2.
49. Stowe TJ, Sedgley CM, Stowe B, Fenno JC. The effects of chlorhexidine gluconato (0,12%) on the antimicrobial properties of tooth-colored ProRoot mineral trioxide aggregate. Journal of Endodontics. 2004; 30:429-31.
50. Kogan P, He J, Glickman GN, Watanabe I. The effects of various additives on setting properties of MTa. Journal of Endodontics. 2006; 32:569-72.
51. Oliveira M, Xavier C, Demarco F, Pinheiro A, Costa A, Pozza D. Comparative chemical study of MTA and Portland cements. Brazilian Dental Journal. 2007; 18(1):3-7.
52. Song J, Mante F, Romanow W, Kim S. Chemical analysis of powder and set form of Portland cement, gray ProRoot MTA, white ProRoot MTA, and gray MTA-Angelus. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2006; 102:809-15.
53. Danesh G, Dammascke T, Gerth HUV, Zandbiglari T, Schäfer E. A comparative study of selected properties of ProRoot mineral trioxide aggregate and two Portland cements. International Endodontic Journal. 2006; 39:213-9.
54. Cardoso Silva C, Barbería E, Maroto M, García-Godoy F. Clinical study of Mineral Trioxide Aggregate in primary molars. Comparison between Grey and White MTA- A long term follow –up (84). Journal of Dentistry. 2011; 39: 187-93.
55. Roberts HW, Toth J, Berzins D, Charlton D. Mineral trioxide aggregate material use in endodontic treatment: A review of the literature. Dental Materials. 2008; 24:149-64.
56. Vasconcelos B, Bernardes R, Cruz S, Duarte M, Padilha P, Bernardineli N, Garcia R, Bramante C, Moraes I. Evaluation of pH and calcium ion release of new root-end filling materials. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2009; 108(1):135-9.
57. Moretti A, Oliveira T, Sakai V, Santos C, Machado M, Abdo R. Mineral trioxide aggregate pulpotomy of a primary second molar in a patient with agenesis of the permanent successor. International Endodontic Journal. 2007; 40(9):738-45.
58. Caceido R, Abbott PV, Alongi DJ, Alarcon MY. Clinical, radiographic and histological analysis of the effects of mineral trioxide aggregate used in direct pulp capping and pulpotomías of primary teeth. Australian Dental Journal. 2006; 51(4):297-305.
59. Aeinehchi M, Dadvand S, Fayazi S, Bayat-Movahed S. Randomized controlled trial of mineral trioxide aggregate and formocresol for pulpotomy in primary molar teeth. International Endodontic Journal. 2007; 40(4):261-7.
60. Noorollahian H. Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomías in primary molars. British Dental Journal. 2008; 204(11):E20.
61. Araki Ribeiro D, Húngaro Duarte MA, Akemi Matsumoto M, Alencar Marques ME, Favero Salvadori DM. Biocompatibility in vitro test of Mineral Trioxide Aggregate and regular and White Portland cements. Journal of Endodontics. 2005; 31(8): 605-7.
62. Steffen R, van Waes H. Understanding mineral trioxide aggregate/Portland-cement: A review of literature and background factors. European Archives of Paediatric Dentistry. 2009; 10 (2): 93-7.
63. Conti TR, Sakai T, Fornetti APC, Moretti ABS, Oliveira TM, Lourenço Neto N, Machado MAAM, Abdo RCC. Pulpotomies with Portland Cement in human primary molars. Journal of Applied Oral Science. 2009; 17(1): 66-9.
64. Sakai T, Moreti ABS, Oliveira TM, Fornetti APC, Santos CF, Machado MAAM, Abdo RCC. Pulpotomy of human primary molars with MTA and Portland cement: a randomized controlled trial. British Dental Journal. 2009; 207: 1-5.
65. Rivera Mijica G, Arróniz Padilla S, Llamosas Hernández E. Estudio comparativo de la filtración del tercio cervical utilizando MTA, cemento Portland y fosfato de zinc como selladores. Oral. 2007; 27: 419-25.
66. Barbosa AVH, Cazal C, Nascimiento DCA, Valverde DFS, Valverde RS, Sobral APV. Propiedades do Cimento Portland e sua Utiliçao na Odontologia: Revisão de Literatura. Pesquisa Brasileira em Odontopediatria e Clinica Integrada. 2007; 7(1): 89-94.
67. França TRT, da Silva RJ, de Queiroz MS, Menezes Aguiar C. Arsenic content in Portland cement: A literatura review. Indian Journal of Dental Research. 2010; 21(4): 591-5.
68. Wucherpfenning Al, Green DB. Mineral Trioxide vs. Portland Cement: Two biocompatible filling materials. Journal of Endodontics. 1999; 25(4): pr 39-pr40.
69. Al-Nazhan S, Al-Judai A. Evaluation of antifungal activity of mineral trioxided aggregate. Journal of Endodontics. 2003; 29:826-7.
70. Sipert C, Hussne R, Nishiyama C, Torres S. In vitro antimicrobial activity of Fill canal, Sealapex, Mineral trioxide aggregate, Portland cement and EndoRez. International Endodontic Journal. 2005; 38:539-43.
71. Araki Ribero D, Mariko Sugui M, Akemi Matsumoto M, Húngaro Duarte MA, Alencar Marques ME, Favero Salvadori DM. Genotoxicity and cytotoxicity of mineral trioxide aggregate and regular and White Portland cements on Chinese hamster ovary (CHO) cells in vitro. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2006; 101: 258-61.
72. Braz MG, Camargo EA, Salvadori DMF, Marques MEA, Ribeiro DA. Evaluation of genetic damage in human peripheral lymphocytes exposed to mineral trioxide aggregate and Portland cements. Journal of Oral Rehabilitation. 2006; 33: 234-9.
73. Lenher P, Allgayer N, Weiger R, Filippi A, Attin T, Krasti G. Tooth discoloration induced by endodontic materials: a laboratory study. International Endodontic Journal. 2012: 1-8.
74. Obando-Pereda GA, Torres-Chávez KE, Salas-Beltrán H, Hofling JF. Análisis de La composiciñon química, capacidad de sellado apical y propiedades antimicrobianas Del MTA y Del cemento Portland. Endodoncia. 2009; 27(3): 111-20.
75. Abdullah D, Pitt Ford TR, Papaioannou S, Nicholson J, McDonald F. An evaluation of accelerated Portland cement as a restorative material. Biomaterials. 2002; 23: 4001-10.
76. Islam I, Chng HK, Yap AUJ. Comparison of physical and mechanical properties of MTA and Portland cement. Journal of Endodontics. 2006; 32:193-7.
77. Holan G, Eidelman E, Fuks AB. Long-term evaluation of pulpotomy in primary molars using Mineral Trioxide Aggregate or Formocresol. Pediatric Dentistry. 2005; 27: 126-36.